Home > Insider Trading > Enzon Pharmaceuticals Inc.

Enzon Pharmaceuticals Inc. (ENZN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

What Do Hedge Funds Think of Enzon Pharmaceuticals, Inc. (ENZN)?

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...

Keep Reading →

November 25th, 2015 - Hedge Funds News

Enzon Pharmaceuticals Inc (ENZN)’s Shares Rally After Special Cash Dividend Announcement

The shares of Enzon Pharmaceuticals Inc (NASDAQ:ENZN) have rallied in excess of 16% in trading today after the company announced a special cash dividend for its investors.

Keep Reading →

July 6th, 2015 - Hedge Funds News

Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot

In a recent filing with SEC, Carl Icahn of Icahn Capital Lp disclosed an activist stake of 4.74 million shares in Voltari Corp (NASDAQ:VLTC).

Keep Reading →

April 1st, 2015 - Hedge Funds News

Seth Klarman's Baupost Group Initiates Stake in Kindred Biosciences Inc (KIN); Trims Holding in Enzon Pharmaceuticals Inc (ENZN)

In two filings with the Securities and Exchange Commission, Baupost Group, a hedge fund managed by Seth Klarman, disclosed reducing its position in Enzon Pharmaceuticals Inc (NASDAQ:ENZN) and adding...

Keep Reading →

January 9th, 2014 - Hedge Funds News

5 Activist Hedge Funds to Watch

Activist hedge funds: While hedge funds follow many different investment philosophies, the industry can be boiled down to two types of managers: the activists and the passivists.

Keep Reading →

October 15th, 2013 - Hedge Funds

Hedge Fund News: Jeff Vinik, Meredith Whitney & Jim Chanos' Thoughts on Oil

Jeffrey Vinik, the money manager who shut his hedge fund earlier this year after returns slumped, is providing $20 million in startup capital for an investment firm run by his former stock picker David...

Keep Reading →

October 10th, 2013 - Hedge Funds News

Icahn Gets Key Board Appointment at Enzon Pharmaceuticals

Icahn, Enzon Pharmaceuticals: In an amended 13D just filed with the SEC, Carl Icahn and Icahn Capital reported that Jonathan Christodoro has been appointed to a Director post at Enzon Pharmaceuticals (...

Keep Reading →

October 9th, 2013 - Hedge Funds News

What Hedge Funds Think About ArQule, Inc. (ARQL)

In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks. A duo of the most innovative are hedge fund and insider trading sentiment.

Keep Reading →

September 3rd, 2013 - News

What's a Smart Cytokinetics, Inc. (CYTK) Investor To Do?

In the eyes of many of your peers, hedge funds are seen as useless, old investment tools of a forgotten age.

Keep Reading →

August 22nd, 2013 - News

OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?

To the average investor, there are many gauges shareholders can use to monitor stocks. Two of the most underrated are hedge fund and insider trading movement.

Keep Reading →

July 8th, 2013 - News